Skip to content
10-K

Annual Report

Creative Medical Technology Holdings, Inc. CELZ

0001477932-25-001736

← back to feed
Filed
Mar 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 22, 2025 1.75M sh
Shares Diluted FY 2024 · Dec 31, 2023 1.41M sh
Stock Repurchased FY 2024 · Dec 31, 2023 $270.95K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$8.03M
Stockholders Equity FY 2024 · Dec 31, 2023 $10.34M
Stockholders Equity FY 2024 · Dec 31, 2022 $15.86M
Current Liabilities FY 2024 · Dec 31, 2023 $371.39K
Total Liabilities FY 2024 · Dec 31, 2023 $371.39K
Current Assets FY 2024 · Dec 31, 2023 $10.27M
Total Assets FY 2024 · Dec 31, 2023 $10.72M
Eps Diluted FY 2024 · Dec 31, 2023 −$3.76
Sga Expense FY 2024 · Dec 31, 2023 $3.56M
Rd Expense FY 2024 · Dec 31, 2023 $1.97M
Net Income FY 2024 · Dec 31, 2023 −$5.29M
Operating Income FY 2024 · Dec 31, 2023 −$5.62M
Gross Profit FY 2024 · Dec 31, 2023 $5.4K
Cost Of Revenue FY 2024 · Dec 31, 2023 $3.6K
Revenue FY 2024 · Dec 31, 2023 $9K